Publikationen, an denen er mitarbeitet Josep Redón Más (7)

2013

  1. Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus

    JAMA Internal Medicine, Vol. 173, Núm. 18, pp. 1682-1692

  2. Efficacy of combination therapy with angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertension

    Expert Opinion on Pharmacotherapy, Vol. 14, Núm. 2, pp. 155-164

  3. Role of dihydropyridinic calcium channel blockers in the management of hypertension

    Expert Review of Cardiovascular Therapy, Vol. 11, Núm. 1, pp. 91-105

2010

  1. Effectiveness of an interventional program to improve blood pressure control in hypertensive patients at high risk for developing heart failure: HEROIC study

    Journal of Clinical Hypertension, Vol. 12, Núm. 5, pp. 335-344

2008

  1. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

    The Lancet, Vol. 372, Núm. 9644, pp. 1174-1183

  2. Telmisartan, ramipril, or both in patients at high risk for vascular events

    New England Journal of Medicine, Vol. 358, Núm. 15, pp. 1547-1559

2006

  1. Effect of NSAID on blood pressure among hypertensive patients with a high cardiovascular risk

    Anales de Medicina Interna, Vol. 23, Núm. 9